NASDAQ
HHS
6 stories
$33M Market cap · 2026-10-12
I think $HHS drifting because S4 taking a while and no news, I am going to buy some more, I think even if STARR doesn’t acquire someone else will. Could be delayed due to the other proposals from the go shop. Or just not able to obtain financing, or administrative burden. $4.35 ish price
$HHS spread kind of wide again. STARR CEO reaffirmed target of YE 2026, and said working on S-4. Gross 12.71%. Annualized 66%. A few other parties got pretty far in the go shop period providing to me a nice Margin of Safety. I sold a chunk at $4.63. Am buying back here. Writeup: https://t.co/dxoWyjD3SE
Positive update for $HHS. The go-shop produced multiple acquisition proposals, and at least one bidder remains in discussions after the deadline. Star has already been notified, so there is now a real path to a superior bid. Full pitch in original tweet👇 https://t.co/PmNZqELqM2
$HHS merger arb with a ~13% spread and closing expected in 1–2 months. Shareholder vote looks straightforward. Main wrinkles are financing consent and illiquid $STRRP consideration, but neither looks fatal. Full pitch on SSI👇 https://t.co/RvUWm71VuZ
Harte Hanks’ $5-per-share sale to Starr Equity offers a 15.7% gross spread, with closing dependent on $15 million of debt financing and…
Star Equity’s $5 per-share Harte-Hanks acquisition offers $2.50 cash plus 0.25 STRRP per share after proration, against a $2 break price.
Companies the stories above are also about, besides HHS.
